RA is a chronic autoimmune disease characterized by high grade-inflammation, and associated with elevated cardiovascular risk, rheumatoid-cachexia and functional impairment. Sedentary behaviour (SB) is linked to heightened inflammation, and is highly pervasive in RA, likely as a result of compromised physical function and persistent fatigue. This high sedentarity may exacerbate the inflammatory process in RA, and hold relevance for disease-related outcomes. The aim of this narrative review is to provide an overview of the definition, measurement and health relevance of SB in the context of RA. Contradictions are highlighted with regard to the manner in which SB is operationalized, and the significance of SB for disease outcomes in RA is outlined. The advantages and disadvantages of SB measurement approaches are also discussed. Against this background, we summarize studies that have reported SB and its health correlates in RA, and propose directions for future research.
Introduction
Sedentary behaviour: definition and health relevance
The term sedentary behaviour (SB)-derived from the Latin term sedere, meaning to sit-is often simply defined as too much sitting [1] . Until recently, a common misapprehension has been that SB merely reflects the absence of purposeful physical activity, defined as moderate activity of 53 metabolic equivalents (METs; 1 MET = oxygen consumed at rest, i.e. 3.5 ml/kg/min; 3 METs reflects moderate paced walking). However, a lack of moderate intensity physical activity should be referred to, more accurately, as physical inactivity [2] . Indeed, current thinking recognizes that SB and physical inactivity are separate constructs, and can be operationalized as such.
In 2012, the SB Research Network (SBRN) defined SB as any waking behaviour characterized by an energy expenditure of 41.5 METs and a sitting or reclining posture [e.g. television (TV) viewing, computer use, reading and driving] [2] . In contrast, physical inactivity is defined as insufficient or irregular engagement in recommended levels of moderate intensity activity 53 METs (i.e. 30 min x 5 days/week for adults) [3] . Thus, physically inactive individuals can also be non-sedentary, where, in the absence of moderate intensity activity, they still engage in substantial amounts of light physical activity (i.e. 1.62.9 METs) and spend little time sitting [3, 4] . Similarly, sedentary individuals can also be physically active, i.e. they spend large portions of the day engaged in low-energy sitting behaviours, but also engage in recommended levels of moderate-to-vigorous physical activity ( Fig. 1 ).
This move towards a more consistent thinking with regard to the modern conceptualization of sedentariness is borne out of recent findings demonstrating that SB holds deleterious consequences for health independently of any beneficial effects of physical activity engagement [411] . In particular, there is evidence that implicates SB as a precursor of heightened systemic inflammation in both healthy and clinical populations, irrespective of the anti-inflammatory effects of physical activity [811] . Indeed, there now exists a considerable amount of evidence demonstrating SB to be an independent risk factor for cardiovascular disease, the metabolic syndrome, sarcopenia and Type 2 diabetes, all of which have chronic systemic inflammation in common [9, 10, 1216] . These independent health effects may result from differences observed in the acute and chronic physiological responses to SB vs physical activity engagement [17] . Indeed, divergent cellular mechanisms are reported to underlie the decrease in lipoprotein lipase (LPL) activity that can occur in response to SB, compared with the increase in LPL observed during physical activity. For example, LPL activity is 510-fold lower in red oxidative muscle fibres during SB, whereas a 2.5-fold increase in LPL activity is observed in white glycolytic muscle fibres after exercise. Similarly, LPL mRNA expression is increased in glycolytic muscles in response to physical activity, where no change is observed in mRNA expression following prolonged sitting [1820] . Low levels of LPL are associated with increased levels of circulating triglycerides and decreased levels of high-density lipoprotein cholesterol [18, 21] -precursors of inflammation and contributors to the progression of cardio-metabolic and cardiovascular disease [22, 23] . Thus, evidence points to the possibility that regulation of LPL activity might represent a key cellular mechanism underlying the independent associations between SB, inflammation and adverse health outcomes.
FIG. 1 Sedentary behaviour vs physical inactivity
Four distinct behavioural profiles representing different levels of engagement in sedentary behaviour, light physical activity and moderate-to-vigorous physical active. Physically active: meeting guidelines for moderate-to-vigorous physical activity (children: 60 min Â 7 days/week; adults: 30 min Â 5 days/week). Physically inactive: absence of engagement in recommended levels of moderate-to-vigorous physical activity. Sedentary: the majority of waking time spent in activities requiring an energy expenditure 41.5 METs and a sitting or reclining posture.
Given that many individuals spend the largest proportion of the day being sedentary (e.g. 5560% of waking hours) [24] , reducing sitting time and SB change have become public health priorities for chronic disease prevention [1, 3] . Accordingly, an increasing number of large-scale cohort studies continue to advance our understanding of the determinants and health consequences of SB [8, 2527] . However, while research in this domain continues to grow exponentially from an epidemiological perspective, far less work has focused on specific clinical cohorts.
Examining the relevance of SB for health outcomes among patient populations for whom physical dysfunction may contribute towards increased sedentariness, particularly where inflammation comprises a substantial component of disease aetiology, is obviously important. A prime example of such a clinical population is individuals living with RA for whom inflammation is a chief contributor towards disease progression, functional disability and other adverse outcomes. Indeed, high levels of SB, which may result from reduced functional ability and persistent fatigue, may perpetuate the adverse consequences of an already heightened chronic inflammatory load, and further contribute towards the risk of cardiovascular disease, metabolic syndrome and inflammation-related cachexia (Fig. 2 ).
SB and RA

Sedentary-inflammation hypothesis
RA is a chronic autoimmune disease characterized by high-grade systemic and local inflammation, joint erosion, musculoskeletal deterioration and functional disability [28] . Common sequelae of uncontrolled high inflammatory load in RA include joint pain and stiffness, fatigue, compromised psychological wellbeing (e.g. depression), reduced quality of life, high CVD risk and cachexia, among others [2938] .
Since SB may relate to increased inflammation, it follows that it may hold implications for such RA features. This may lead to a vicious cycle, where compromised physical function, heightened fatigue and increased local disease activity may increase sedentariness, which, in turn, may further exacerbate inflammation and contribute towards the severity of RA-related health outcomes [39] . Figure 2 describes the proposed pathways by which this cyclic relationship may occur, underpinning the need for more research into the implications of SB for people with RA.
In this article we consider SB specifically in the context of RA. We discuss current approaches utilized to measure it, summarize available data concerning its levels and health-related correlates in RA, highlight directions for future research and provide recommendations for researchers pursuing work in this field.
Measurement of SB
The established definition of SB stipulates a consideration of both low energy expenditure 41.5 METs and a sitting or reclining posture [2] . Thus, in order to accurately quantify levels of SB, measures should enable valid and reliable assessment of both the energy requirements of the activity and posture (i.e. whether sitting or reclining vs. standing). Moreover, assessment methods should be validated for measurement of SB among the specific populations in which they are used. Assessment tools should also enable continuous data monitoring to permit the measurement of free-living SB, and include the ability to distinguish sleep from SBs engaged in during waking hours. Finally, the ideal measure of SB would be low cost, easy for participants to use, and produce data that are easily analysed by researchers [40] .
When deliberating the utility of different measurement approaches it is also important to appreciate the components of SB proposed to be relevant to health [41] . Indeed, it is not only the total amount of sedentary time accumulated that may hold implications for health-related outcomes, but also the manner in which it is accumulated. Specifically, the number and length of sedentary bouts (uninterrupted sedentary periods) and the frequency of interruptions in sedentary time (sedentary breaks) have been linked to biomarkers of chronic disease in both clinical and non-clinical populations [810, 26] . For example, prolonged sedentary bouts are adversely associated with CRP, triglycerides, high-density lipoprotein cholesterol and plasma glucose [9, 10, 26], whereas more frequent sedentary breaks associate with beneficial changes in levels of these biomarkers [8, 9] . The importance of examining the contribution of specific behaviours to total sedentary time has also been underlined: certain SBs, such as TV viewing, may be more detrimental to physical health than others [8] . Indeed, concurrent engagement in other unhealthy activities while participating in more passive (relative to mentally active) sedentary activities has been reported to result in increased adiposity and poorer cardio-metabolic health (e.g. TV time snacking) [42] . Accordingly, the health-related constituents of SB have been conceptualized using the SITT formula as follows [43] : S ITT -SB frequency (number of bouts of certain duration); S I TT -interruptions (e.g. frequency of getting up during sedentary time); SI T T -time (duration of SBs); SIT T-type (mode or context of SB). In the following sections, we provide information regarding the advantages and disadvantages of different SB measurement approaches that are currently used to assess one or more components of SITT (Tables 1 and 2 ), including a focus on the application and validity of measures used in RA studies to date (Table 3) . Tables 1 and 2 provide an overview of current SB measurement methods. The cost, user-reported ease, and burden of use for each are described ( Table 1 ). The ability of each measure to assess SITT components, the reported validity and reliability of instruments, and the capability offered by objective measures to assess each facet www.rheumatology.oxfordjournals.org of SB (sedentary energy expenditure and posture) is also indicated ( Table 2) .
Current SB measurement methods
Overview
Self-report methods
Until recently, questionnaire-based methods have been most frequently used to investigate SB due to their low cost, low participant burden and ease of use [41] (Table 1) . In general, questionnaires involve asking individuals to retrospectively estimate their total sitting time ( SI T T ) and/ or time spent in specific types ( SIT T) of sitting behaviours (e.g. TV viewing). Diaries can also be used to gather information in this way, on the basis of time-referenced recall of behaviour (e.g. at the end of each day). However, the pervasive and varied nature of SBs undertaken throughout the day may limit the accuracy of recall. As a result, low validity and reliability are frequently observed with regard to retrospective self-report measurement methods (Table 2) [40, 41, 44] .
To alleviate some of the problems associated with behavioural recall (e.g. social desirability [41] ), diary-based methods that require repeated momentary time sampling (e.g. every 15 min) can be employed to gather real-time accounts of SB. A clear advantage of this approach (termed Ecological Momentary Assessment; EMA [45] ) is that it enables assessment of behaviour as it occurs. However, the time taken to complete EMA and the advanced statistical data processing needed to analyse the data collected, mean this method results in a moderate-to-high burden for both the participant and the researcher. Still, the contextual data gathered via EMA may also provide valuable insight with regard to the social and physical environmental factors predictive of the different components of SB (SITT), among different populations.
Objective methods
Addressing some of the limitations inherent in self-report, attention is shifting towards technological innovations in objective monitoring of SB, such as accelerometers and, to a lesser extent, posture sensors [40, 41, 46] . Accelerometers are small, lightweight devices, usually worn on the wrist, hip or upper arm, that enable data pertaining to movement patterns (e.g. trunk, wrist or ankle accelerations) to be recorded continuously over several days. Movement data recorded by devices are typically calibrated against energy expenditure assessed via indirect calorimetry in order to identify a sedentary threshold or 'cut-point' at which accelerometer output (e.g. Signal Vector Magnitude (gravity subtracted, SVMgs), or accelerometer activity counts [47] ), can be interpreted to classify behaviours requiring 41.5 METs [4850]. Continuous behaviour monitoring via accelerometry therefore enables measurement of SB frequency (S ITT ), sedentary interruptions ( S I TT , where activity counts cross the sedentary threshold), and sedentary time ( SI T T ). Still, while offering a somewhat comprehensive assessment of SITT components, it is not clear which sedentary cut-point should be employed in studies of different populations. Currently, a threshold of <100 counts per minute (cpm) is almost universally used to represent sedentary time among diverse cohorts [41] . However, this cutpoint-derived from calibration studies of healthy adults [39] -has not been validated among different groups for whom the energy requirements of behaviour may vary substantially (e.g. older adults and patient groups) [51] . Indeed, where accelerometers have been used to measure physical activity in a particular population, it is common for researchers to develop and validate population-specific cut-points to enable more accurate classification of the frequency, intensity and duration of their physical activity engagement [52, 53] . A further drawback of using accelerometers to quantify SB on the basis of accelerations or movement counts is that non-sedentary activities requiring little movement may be misclassified as sedentary. For example, accelerometers may yield movement counts associated with sedentary activity (i.e. <100 cpm) during activities where energy expenditure is increased above sedentary levels (e.g. standing while lifting weights). Researchers have sought to overcome this limitation with the application of combined sensors that measure both movement and physiological response to activity (e.g. via heart rate or skin temperature) [54, 55] . Still, even when combined with physiological sensory ability, accelerometers lack the facility to accurately capture whether activities are undertaken while sitting/ lying (i.e. sedentary) or while standing (non-sedentary).
Posture sensors represent a recent advancement in SB research and are being used with increasing regularity in this field [46] . These devices are typically worn on the front of the thigh, and use accelerometer-derived information regarding thigh position (towards gravity) to determine posture classification (i.e. time spent sitting/lying/standing). Available evidence suggests posture sensors, such as the activPAL, may offer a valid measure of SB frequency (S ITT ), sedentary interruptions ( S I TT ), and sedentary time ( SI T T ) [56] . Still, it is important to recognize that with the application of posture sensors, sedentary energy expenditure is inferred indirectly based on the assumed energy cost of sitting or lying (i.e. 41.5 METs) [46] . Thus, when used in isolation, both postural sensors and accelerometers are limited in the extent to which they can accurately measure sedentariness in alignment with the SBRN definition.
Multi-site monitors-such as the Intelligent Device Energy Expenditure and Activity (IDEEA) monitor and the Dynaport Activity Monitor (DAM)-may offer a novel solution to this challenge [57] . These devices use multi-site sensor attachment (e.g. on the waist and the thigh) to determine time spent lying, reclining, sitting, standing and in locomotion, as well as the energy cost (METs, IDEEA monitor) or movement intensity (m/s 2 , DAM) of activities [57, 58] . However, the high cost of multi-site monitors combined with the high participant and researcher burden, means these instruments have not been employed extensively to study SB. Continued development of these approaches and subsequent validation work, will help to confirm their effectiveness for measuring SB in different populations.
Application and validity of SB measurement methods in RA [59, 60] . Considering objective measurement approaches, the activPAL has been found to offer an accurate assessment of time spent sitting, lying, standing and walking in people living with RA, when compared with direct observation. However, its validity for quantifying step count and the number of sedentary time interruptions has been queried (i.e. underestimation by 26 and 36%, respectively) [56] . The validity of the Sensewear armband (SWA) has also been examined, with data indicating this device to underestimate sedentary time in RA (as computed using manufacturerderived proprietary algorithms) when compared with energy expenditure assessed via indirect calorimetry [61] . This underestimation was suggested to be due to the elevated resting energy expenditure observed in this patient population, relative to healthy adults in which the proprietary SWA algorithms tested were developed [61] . As such, these findings support the thesis that inaccuracies in sedentary time estimation may arise when studies in RA employ SB algorithms derived from validation studies in healthy adults (e.g. <100 cpm, Table 3 ) [59, 60, 62, 63] .
Further perpetuating challenges surrounding SB measurement validity, discrepancies also arise with regard to the sedentary MET definition applied in RA studies. Specifically, while most studies in other populations have defined SB as 41.5 METs in line with the SBRN definition (based on <100 cpm), recent research in RA has considered activities requiring 41 MET to represent sedentary activity [63, 64] : it is therefore likely that common seated behaviours with an energy cost of between 1 and 1.5 METs (e.g. sitting and reading, typing or watching TV) are not captured in these studies [6567] . Thus, the prevalence of sedentarity in RA may have been significantly underestimated in this work. Moreover, the application of inconsistent definitions of SB precludes comparisons across studies (of both RA and non-RA populations), hindering advancement in the understanding of SB epidemiology in this patient group.
Against this background, in the following sections, we describe the results of current research that has sought to investigate levels and health-related correlates of SB in RA. We critically appraise the measurement approaches used and analytical decisions employed, and highlight how these methodological decisions may have impacted upon results reported and their interpretation.
Levels and health correlates of SB in RA
Levels of SB Self-reported SB Table 4 includes the results of the seven studies that have sought to measure levels of SB in RA using self-report [5860, 6264, 6876]. Semanik and colleagues [73] were among the first to investigate levels of SB in RA: using the YPAS, 48% of participants reported sitting for >6 h/day. More recently, Gilbert et al. [60] -also using the YPAS-found that people with RA spend $13 h sitting/ day, with 53% reporting >8 h daily sitting time. This is substantially higher than estimates of sedentary time observed in the majority of other self-report studies, which show 46 h sitting/day in RA. There may be several reasons for such divergent results, including the different populations of RA patients studied, the time period during which studies were conducted, and the manner in which sitting time was estimated. For example, Yu et al. [59] and Greene et al. [72] relied on participant recall of total daily sitting time in their studies using the IPAQ and Physical Activity Disability Survey (PADS), respectively. In contrast, Gilbert and colleagues [60] calculated daily sitting time as: 24 h, minus the sum of self-reported physical activity and sleep time. In addition, we have proposed a cyclical relationship between inflammation, sedentariness and further perpetuation of inflammation [39] . With this in mind, it is also important to consider that the higher estimates of sitting time observed in some studies might reflect elevated disease activity and/ or a longer disease duration of the particular patient sample studied. Indeed, comparison of descriptive data indicates patients recruited by Gilbert et al. [60] represented individuals with active disease (DAS-28 = 6.44) and established RA (13.4 years) [60] . In contrast, studies reporting relatively lower estimates of sedentary time engagement included patients with less active disease (e.g. DAS-28 = 2.6) [68] , and shorter disease durations (e.g. 7.2 and 11 years) [59, 68] .
Despite evidence demonstrating specific SBs to be particularly detrimental to health (e.g. TV viewing) [8] , only two studies have distinguished between types of behaviour when assessing sedentary time accumulation in RA. Kramer et al. [70] and Giles et al. [71] reported TV viewing to occupy around 2 h/day in people with RA.
Objectively assessed SB
Munneke and colleagues [58] were the first to investigate the prevalence of objectively assessed SB in RA using the DAM (Table 4) . Results indicated that over a 24 h period, people with RA spent $30.5% of time sitting and 42.1% lying. However, this study did not determine the MET costs associated with engagement in these activities. Rather, average 'movement intensity' was calculated as the vector of trunk accelerations in longitudinal and frontal planes (i.e. m/s 2 ) [77] . Analyses also did not distinguish waking SB from sleep time, which may have resulted in inflated SB estimates. The distinction between waking SB vs sleep is certainly important to make [40] . That is, sleep is a vital restorative process and should not be counted as sedentary time when examining levels and health-related concomitants of SB.
Following this initial work, it was over a decade later when other researchers began to employ objective devices to estimate daily sedentary time in RA. In sum, these studies report between 9 h and 19 h sedentary time each day in people with RA (Table 4) [59, 60, 63, 64, 76] . These highly variable estimates are again most likely www.rheumatology.oxfordjournals.org www.rheumatology.oxfordjournals.org due to methodological discrepancies, including the following: the instrument used (e.g. GT3X vs RT3 accelerometer vs activPAL), the manner in which SB is defined and subsequently quantified [e.g. <100 cpm (equating to 41.5 METs), vs 41 MET vs time sitting/lying] and the data collection protocol (e.g. inclusion vs exclusion of sleep time) (Table 4) . However, a lack of detailed reporting with regard to sedentary measurement or analysis protocols within studies, means the extent to which each of these factors may contribute towards differing sedentary time estimates in RA is difficult to establish [59, 63, 64, 74, 75] .
Health correlates of SB in RA Several recent studies have sought to examine healthrelated correlates of SB for people living with RA, including associations with disease activity, physical function, muscle density, bone mass and cardiovascular risk [59, 63, 7072, 75] .
Disease activity
One study has examined the link between SB and RAassociated disease activity. In a cross-sectional study, Khoja et al. [63] reported SB measured by the SWA to be inversely related to disease activity score in a group of RA patients. However, as with all cross-sectional studies, the causal direction of this association cannot be determined. Indeed, SB could represent both a consequence and a cause of increased disease activity in RA [7880] . That is, early RA patients, and/or patients with controlled disease, may be better able to avoid excess sedentarity, relative to individuals with established RA and/or more active disease. Prioreschi et al. [75] are the first to examine longitudinal associations between SB and several health outcomes in RA. They reported reductions in SB occurred alongside declines in morning stiffness following DMARD therapy. Such findings underline the need for carefully designed longitudinal studies that could address issues of directionality/ causality of associations between inflammation, SB and different health outcomes in RA. In a similar vein, studies that compare the treatment efficacy of biologic therapies vs more conventional synthetic DMARDs for concurrently attenuating disease activity and SB would offer an interesting research agenda.
Muscle density and functional disability
Greene et al. [72] were the first to report negative consequences of SB in RA, demonstrating higher self-reported time spent sitting and lying to be adversely associated with disability and pain. Giles et al. [71] later showed self-reported daily TV time to associate with deleterious consequences for functional ability in RA. Specifically, this cross-sectional study revealed each hour of TV viewing per day was associated with a 0.09 U increase in functional disability. The subsequent findings of Kramer et al. [70] showed that TV viewing was negatively related to total muscle density, while total muscle density was positively associated with functional ability. Thus, decreased muscle density may represent a plausible mechanism underlying the association between SB and physical function. Findings such as these support the hypothesis of a sedentary-inflammation pathway in RA, and require further investigation. That is, sedentary time may exacerbate inflammation-induced cachexia, a chief contributor towards reduced muscle density and associated declines in physical function in RA [81] .
Bone mass
A recent study indicates SB may also be linked to lower bone mass in RA [62] , holding implications for the development of osteopenia and subsequent osteoporosis. Prioreschi et al. [62] reported patients with below average bone mass accrued 2 h more accelerometer-assessed sedentary time each day (defined as <100 cpm, equating to 41.5 METs) than those with a normal bone mass. The role of pro-inflammatory cytokines have been underlined in the development of osteoporosis in RA, with evidence for the efficacy of biologic therapies targeting inflammatory cytokines protecting against bone degradation [82] . Heightened local and systemic inflammation resulting from SB in RA may, therefore, also contribute towards increased risk of osteoporosis in these patients.
Cardiovascular risk
Khoja et al. [63] also reported detrimental associations of SB with a number of cardiovascular risk factors (i.e. BMI, blood pressure, insulin resistance, cholesterol), as well as functional disability in RA. However, given that SB was defined as activities 41 MET in this study, conclusions could not be drawn concerning the relevance of common SBs requiring 11.5 METs (e.g. sitting and reading a book or newspaper) for CV risk and other specific outcomes. Nevertheless, Yu et al. [59] reported in a recent crosssectional study that accelerometer-assessed SB (defined as <100 cpm, equating to 41.5 METs) was negatively related to cardiorespiratory fitness in RA.
Future research recommendations and directions
Research to date suggests high levels of sedentariness in people living with RA, which appears to be a significant contributor to their disease burden. However, to further our understanding of SB and its health consequences in this patient group, a great deal of work that employs a more rigorous approach specific to RA is required. Considering the methodological shortcomings and inconsistencies among past SB research in RA, we propose a standardization of methodology that could include the following components. First, the definition of SB as advocated by the SBRN should be employed consistently across studies. Second, a combination of self-report (e.g. diaries) and objective measures of SB should be utilised to effectively examine the multiple constituents of SITT. Third, objective devices ought to include, where possible, a measure of both posture and energy expenditure. Fourth, studies employing accelerometry should use validated cut-off points commensurate with activities characterized by 41.5 METs in people living with RA; where possible disease-state-specific cut-points (e.g. early vs established RA, active vs inactive RA) should also be developed and validated to take into account inflammatory and metabolic variability observed within RA.
Fifth, SB accumulated during waking hours should be distinguished from time sleeping. Sixth, there should be clarity about data collection protocols and analytical decisions employed (e.g. cut-off points, algorithms used etc.).
On the basis of such recommendations, future research priorities in the field of SB in RA should include the following. First, validation of self-report instruments, and labbased calibration and validation studies of objective devices for measurement of SB in RA-to include characterization of the energy cost of common SBs (i.e. activities undertaken while sitting and lying) and standing without ambulation. Second, application of validated devices to enable accurate measurement of levels of SB in RA, including patterns of sedentary time accumulation as conceptualized by SITT. Third, studies designed specifically to examine the directionality (including bi-directionality) of links between SB, inflammation, physical and psychosocial health outcomes in RA-with particular emphasis on disease activity, rheumatoid cachexia and cardiovascular risk profile. These should also examine whether associations with such health outcomes occur independently of levels of light, moderate and vigorous physical activity engagement.
We would like to emphasize that, as yet, no studies have examined the implications of SB for psychological health and wellbeing in RA. This is perhaps due to the assumption that SB may contribute towards adverse health outcomes in these patients via physiological (e.g. inflammation) rather than psychological mechanisms. We therefore propose a parallel research agenda concentrated on investigating the contribution of SB to adverse psychological health outcomes in RA (e.g. depression, subjective vitality).
Conclusions
SB has emerged as a major contributor to the risk of developing, and to the outcome of, chronic disease independently of engagement in physical activity. Evidence indicates this is likely due to the heightened systemic inflammation resulting from high levels of sedentariness. The potential relevance of SB for health outcomes in RA is of obvious importance and, notwithstanding methodological difficulties that can be resolved, should be investigated further. Such research may inform the development of effective SB change interventions, which are likely to improve health and enhance quality of life in people with RA.
Review criteria
The articles cited in this review (Table 4) were found by searching the terms sedentary and rheumatoid arthritis in PubMed (up to January 2016). The search returned 55 articles. An additional search with the terms 'sitting' and Rheumatoid Arthritis returned a further three articles (after cross-checking for duplicates). Abstracts and full texts were reviewed by the main author, to determine the definition and measurement of SB employed. Studies retained for inclusion in this review are those that defined SB as distinct from physical inactivity (i.e. a lack of purposeful/health enhancing physical activity above a moderate intensity), and operationalised SB in accordance with either low energy expenditure (i.e. 41.5 or 41 MET) or behaviours undertaken in a sitting or reclining posture. All procedures were in line with published guidelines for writing a narrative review [83] .
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Strawberry gingivitis as a manifestation of granulomatosis with polyangiitis
A 55-year old female was referred because of progressive gingivitis. Her medical history was unremarkable. Symptoms had developed over the course of a month, starting with slight redness and tenderness of her upper and lower gums, subsequently progressing into painful, easily bleeding, deeply red and swollen lesions (Fig. 1) . She felt tired, had lost about six pounds and she reported a backache between her left scapula and spine. Physical examination showed good oral hygiene and symmetrically enlarged cervical lymph nodes. Laboratory evaluation only showed a mildly elevated level of CRP (18 mg/l). Additional laboratory and urinary evaluations and a chest X-ray were unremarkable. A gingival swab culture was negative. The initial gingival biopsy demonstrated extensive chronic inflammation, but was too small to find disease-specific clues. Subsequently, a consulted specialized oral surgeon recognized the gingival lesions as 'strawberry gums' indicative of granulomatosis with polyangiitis (GPA) [1] . Anti-nuclear cytoplasmic antibodies were tested and showed a cytoplasmic staining pattern directed against PR3. A repeated gingival biopsy showed inflammatory changes with granuloma formation and signs of vasculitis, confirming the diagnosis of GPA [2] . The patient received remission-induction treatment with glucocorticoids and MTX. One month later, the gingival inflammation had greatly improved and her backache had disappeared. The diagnosis of ANCA-associated vasculitis remains challenging, and recognizing mucocutaneous manifestations such as strawberry gums can be an important clue to early diagnosis of GPA. management of ANCA associated vasculitis. BMJ 2012;344:e26. 
